Skip to main content
. 2013 Oct 25;2(5):e000338. doi: 10.1161/JAHA.113.000338

Figure 3.

Figure 3.

Reduction of left ventricular end‐systolic volume (ESV) in the POSEIDON study. MDCT images (4 chamber and short axis view) of a patient with chronic ischemic cardiomyopathy (A) before (ESV 126.9 mL) and (B) after transendocardial stem cell injection (TESI) with 20 million autologous MSCs (ESV 77.1 mL). MDCT indicates multi‐detector computer tomography; MSCs, mesenchymal stem cells; POSEIDON, PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis.